Trials / Completed
CompletedNCT01213693
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
Long-term Effects of Inhaled Corticosteroids (ICS) Treatment on Sputum Bacterial and Viral Loads in Chronic Obstructive Pulmonary Disease (COPD) Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Università degli Studi di Ferrara · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Exacerbations are important events in the natural history of chronic obstructive pulmonary disease (COPD). Beside the acute (and prolonged) clinical impact, there is evidence that exacerbations negatively affect the natural history of the disease; e.g. lung function decline is accelerated in patients with frequent exacerbations. Bacteria are considered the most relevant cause of exacerbations, but there is evidence that viral infections are equally contributing. Either alone or in combination with viruses, airway bacterial load in stable COPD correlates with both the frequency of exacerbations and the decline in lung function. A long-term clinical trial recently showed that the regular treatment with inhaled corticosteroids (ICS) increases the risk of infectious events such as pneumonia, whereas it reduces the frequency of acute COPD exacerbations in COPD. In a recent study it was found that airway bacterial load increases over time (1 yr follow up) in stable COPD. In this study, virtually all patients (93%) were treated with ICS. This study is designed to evaluate whether long-term (1 year) ICS treatment increases viral and/or bacterial load in the sputum of COPD patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salmeterol/Fluticasone combination | Salmeterol/Fluticasone 50/500 mcg 1 inhalation bid |
| DRUG | Salmeterol | Salmeterol 50 mcg 1 inhalation bid |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2013-05-01
- Completion
- 2013-11-01
- First posted
- 2010-10-04
- Last updated
- 2016-04-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01213693. Inclusion in this directory is not an endorsement.